Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplement good manufacturing practices final rule provides "a very flexible framework for required testing," said Vasilios H. Frankos, director of the dietary supplement programs division for FDA's Center for Food Safety and Applied Nutrition
You may also be interested in...
US Supplement Market Growth: Is The Industry In Its Own Way?
Longtime supplement industry attorney Scott Bass says supplement manufacturers should work with FDA as an ally, including registering products with the agency pre-market, while FDA's second-in-command for supplement industry oversight, Robert Durkin, says the agency is not interested in preventing more safe products from reaching the market.
Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety
Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.
Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety
Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.